SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-16-099219
Filing Date
2016-02-23
Accepted
2016-02-23 16:39:04
Documents
1
Period of Report
2016-02-23
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K a15-23423_48k.htm 8-K 19988
  Complete submission text file 0001104659-16-099219.txt   21246
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15006 | Film No.: 161448844
SIC: 2835 In Vitro & In Vivo Diagnostic Substances